Table 3 Adjusted models of asthma morbidity
| Â | Â | Coefficient (95% CI) | Â | OR (95% CI) | Â |
|---|---|---|---|---|---|
| Â | FEV1 | FVC | ACQ | AQLQ | Resource utilization |
Obstructive sleep apnea |  − 0.01 (− 0.17, 0.16) | 0.01 (− 0.19, 0.2) | 0.36 (0.06, 0.65) |  − 0.53 (− 0.85, − 0.21) | 1.51 (0.83, 2.81) |
Age |  − 0.03 (− 0.03, − 0.02) |  − 0.03 (− 0.04, − 0.03) | 0.00 (− 0.01, 0.01) |  − 0.01 (− 0.02, 0.00) | 1.01 (0.99, 1.03) |
Female sex |  − 0.86 (− 1.04, − 0.68) |  − 1.20 (− 1.42, − 0.99) | 0.24 (− 0.08, 0.56) |  − 0.59 (− 0.94, − 0.24) | 1.96 (1.02, 3.8) |
Racea | Â | Â | Â | Â | Â |
Black/AA |  − 0.44 (− 0.63, − 0.25) |  − 0.74 (− 0.96, − 0.52) | 0.26 (− 0.08, 0.6) |  − 0.52 (− 0.89, − 0.15) | 1.65 (0.83, 3.28) |
Hispanic/Latino |  − 0.20 (− 0.37, − 0.03) |  − 0.52 (− 0.72, − 0.32) | 0.25 (− 0.06, 0.57) |  − 0.65 (− 0.99, − 0.31) | 1.74 (0.93, 3.27) |
Other |  − 0.15 (− 0.39, 0.09) |  − 0.38 (− 0.66, − 0.10) | 0.34 (− 0.08, 0.76) |  − 0.48 (− 0.95, − 0.01) | 0.93 (0.39, 2.15) |
BMI | 0.00 (− 0.01, 0.00) |  − 0.01 (− 0.02, 0.00) | 0.01 (− 0.01, 0.02) | 0.00 (− 0.02, 0.01) | 1.05 (1.02, 1.09) |
L − arginine metabolitesb |  |  |  |  |  |
Arginine:ADMA |  − 0.01 (− 0.26, 0.24) | 0.01 (− 0.28, 0.3) |  − 0.23 (− 0.68, 0.22) | 0.47 (− 0.01, 0.96) | 0.59 (0.23, 1.46) |
Proline |  − 0.01 (− 0.17, 0.15) | 0.01 (− 0.17, 0.19) | 0.13 (− 0.15, 0.40) |  − 0.21 (− 0.51, 0.09) | 1.14 (0.65, 1.98) |
Arginine availability index |  − 0.23 (− 0.48, 0.01) |  − 0.23 (− 0.52, 0.06) | 0.22 (− 0.22, 0.66) |  − 0.34 (− 0.82, 0.15) | 1.81 (0.73, 4.56) |